PRIM: PT Royal Prima Tbk - Summary | Jitta

PT Royal Prima Tbk

IDN:PRIM

Price
Rp117.00
Loss Chance
58.0%
1.72JITTA SCORE
100.00%Over Jitta Line
Jitta Ranking
570 / 826
Grow your money with Jitta Ranking. See details.
HISTORICAL JITTA SCORE
Jitta Factors
Growth Opportunity (28)
Recent Business Performance (17)
Financial Strength (51)
Return to Shareholders (3)
Competitive Advantage (24)
Jitta Signs
Revenue and EarningEarning loss detected in 2025
Operating MarginInconsistent
Recent Business PerformanceEarning decline 5.41% in the last year
SG&A to SalesIncreasing
Key Stats
Jitta Score
Jitta Line
1.72
100.00%
4.24
711.02%
Health Care Facilities
4.21
> 1,000%
5.54
14.59%
7.08
14.17%
COMPANY DESCRIPTION
PT Royal Prima Tbk engages in providing hospital services and drugs in Indonesia. The company operates its hospitals under the Royal Prima Medan, Royal Prima Jambi, and RSU Royal Prima Marelan names. The company also provides health services, such as inpatient and outpatient medical services, including specialist and sub-specialist care. In addition, the company offers orthopaedic, eye, neurology, internal medicine, obstetrics and gynaecology, heart, lung, Ent-kl, urology. Further, it provides other services, including general surgery, surgical oncology, plastic surgery, pediatric surgery, neurosurgery, digestive surgery, dermatologist and venereologist, psychiatric, dental polyclinic, oral surgery, vascular surgery, kidney and hypertension, endocrine metabolic diabetes. The company was founded in 2013 and is based in Jakarta, Indonesia.